October 8, 2015
Recommended Topic Related To:


"A new WHO guideline recommends adults and children reduce their daily intake of free sugars to less than 10% of their total energy intake. A further reduction to below 5% or roughly 25 grams (6 teaspoons) per day would provide additional health b"...


KCL in D5NS Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 7/23/2015

KCL in D5NS (potassium chloride in 5% dextrose and sodium chloride injection) is a fluid and electrolyte replenishment and caloric supply used as a source of water, electrolytes and calories. Common side effects of KCL in D5NS include fever, increase in blood plasma volume, or injection site reactions such as infection, redness, pain, or swelling.

Dosage of KCL in D5NS is dependent upon the age, weight and clinical condition of the patient as well as laboratory determinations. KCL in D5NS may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, KCL in D5NS should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Our KCL in D5NS (potassium chloride in 5% dextrose and sodium chloride injection) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

KCL in D5NS FDA Prescribing Information: Side Effects
(Adverse Reactions)


Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia.

If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.

Read the entire FDA prescribing information for KCL in D5NS (Potassium Chloride in 5% Dextrose and Sodium Chloride Injection)

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Weight Loss Wisdom

Get tips, recipes and inspiration.